PNC Financial Services Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
GAM
PNC Financial Services Group's SBIO Position: Q2 2026 in Review
PNC Financial Services Group increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 33% in Q2 2026, buying an estimated $3.56K and bringing the position to 265 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3852.
PNC Financial Services Group first reported a position in SBIO in Q2 2025 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- PNC Financial Services Group held 265 shares of ALPS Medical Breakthroughs ETF worth $17.1K as of Q2 2026.
- PNC Financial Services Group bought 65 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $3.56K.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3852 holding.
- PNC Financial Services Group first reported a position in ALPS Medical Breakthroughs ETF in Q2 2025 and has held it in 5 quarters since.
- 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.